Articles Tagged With:
-
Hypertension in Adults: An Update
Hypertension remains the leading cause of death and disability-adjusted life years globally, accounting for 10.4 million deaths per year. In the United States, hypertension accounts for more cardiovascular disease deaths than any other modifiable risk factor and is second only to cigarette smoking as a preventable cause of death for any reason.
-
Infectious Disease Alert Updates
A Reservoir of Pharyngeal GC; Difficult-to-Treat vs. Standard Multidrug Resistance
-
Malaria: At Last a Vaccine
The World Health Organization has recommended the use of the first effective malaria vaccine.
-
Bacillus cereus Causing an Anthrax-Like Pneumonia
Bacillus cereus group organisms may cause a rapidly fatal pulmonary infection consistent with anthrax.
-
Can Antibiotics Lead to Colon Cancer?
Swedish researchers saw an association between frequent antibiotic use and proximal colorectal cancer.
-
IDWeek 2021: Skipping Along with Staphylococcus aureus
A single set of blood cultures may be inadequate to document clearance of Staphylococcus aureus bacteremia in some patients.
-
IDWeek 2021: Gram-Negative Bacteremia: Are Follow-Up Blood Cultures Routinely Necessary?
A study of significantly immunocompromised patients with gram-negative bacteremia concluded that the routine use of follow-up blood cultures to document clearance is not warranted.
-
IDWeek 2021: Baricitinib for COVID-19 Patients Receiving Invasive Mechanical Ventilation or ECMO
Baricitinib significantly reduced mortality in patients with COVID-19 receiving mechanical ventilation or extracorporeal membrane oxygenation.
-
Prophylactic Probiotics Do Not Reduce the Risk for Developing Ventilator-Associated Pneumonia
A multicenter, randomized, placebo-controlled clinical trial revealed the use of prophylactic probiotics did not reduce the risk for developing ventilator-associated pneumonia or improve other outcomes for intensive care unit patients, compared to placebo.
-
COVID-19 Vaccination and Myocarditis
Receipt of a COVID-19 mRNA vaccine is associated with a small but real risk of development of myocarditis, predominantly in young males. The vast majority of cases are mild, self-limited, and require no intervention.